- Open Access
Clinical ethics recommendations for the allocation of intensive care treatments in exceptional, resource-limited circumstances: the Italian perspective during the COVID-19 epidemic
Critical Care volume 24, Article number: 165 (2020)
On February 21, 2020, the first person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), the virus causing coronavirus disease 2019 (COVID-19), was identified in Italy. In the following days, despite the restrictive public health measures applied to avoid the spread of the infection , the number of cases sharply increased. As of March 8, 2020, Italy was the 2nd most affected country in the world.
In one of the largest reports from China, 5% of COVID-19 patients required admission to the intensive care unit (ICU) . Since the beginning of the COVID-19 outbreak, the availability of ICU beds has been recognized as one of the major public health concerns in Italy, where a total of 5090 ICU beds (8.42/100,000 inhabitants) were reported in 2017 . Despite further efforts have been done to contain the number of cases and extraordinary measures have been put in place, the dramatic increase of ICU admission abruptly overwhelmed the ICU capacity, mostly in Lombardy and in the nearby regions of Northern Italy.
From the evidence available so far, a considerable proportion of subjects diagnosed with COVID-19 infection requires ventilatory support due to severe hypoxemia in the context of interstitial pneumonia. The interstitial lung disease is potentially reversible, but the acute course of the disease can last several days, and ventilatory support may be needed for weeks . These clinical considerations imply that caring for patients with severe pneumonia from COVID-19 can be very demanding in terms of the number of devices and staff required.
As of March 6, 2020, the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) issued a series of recommendations  and relevant ethical considerations to better inform the clinicians involved in the care of critically-ill COVID-19 patients, in a setting where a disproportionate number of patients requiring life-sustaining treatments was rapidly saturating both the existing and the newly set-up ICU beds. The most relevant recommendations are summarized in Table 1.
The emerging epidemic is leading to a substantial increase in the number of patients requiring prolonged ventilatory support for acute respiratory failure, potentially resulting in severe imbalances between the population clinical needs and the overall availability of ICU resources. In this scenario, criteria for ICU admission (and discharge) may need to be driven not only by the principles of clinical appropriateness and proportionality of care, but also by criteria of distributive justice and appropriate allocation of the healthcare resources, that may be more limited than usual.
The primary aim of these recommendations is therefore to supply a common framework for the admission of patients to intensive care treatments in resource-limited circumstances. These recommendations should be shared maximally within all the involved healthcare providers.
Bioethical reasoning has inspired several operative instructions for the field of disaster medicine. In this area, healthcare providers must be supported during their difficult decision-making process. As an extension of the principle of proportionality of care, in the context of a severe shortage of ICU resources, these should be preferentially allocated to patients with the higher possibility of therapeutic success. Therefore, the aim is to privilege the greater chance to successfully overcome critical illness with a greater probability to maintain a good quality of life.
A single patient’s actual need for ICU treatments should be therefore integrated with additional criteria for ICU admission, taking into account the type and severity of the current disease, comorbidity, the presence and reversibility of organ failures, and the potential for recovery. It follows that within the foregoing context, the “first come, first served” criterion for ICU admission does not necessarily have to be followed.
Because of the rare occurrence of large-scale catastrophic events, the healthcare staff may not be very familiar with the criteria applied for triage during mass casualty events. The availability of resources may not always be part of the clinical decision-making process operated on a single patient, until resources become so limited that it is not possible to treat all patients who may hypothetically benefit from a specific treatment.
The application of restrictive (rationing) policies is justifiable only if all the relevant stakeholders (“task forces,” hospitals, institutions) have already tried to increase the availability of resources and have already assessed the feasibility and safety to transfer patients to other hospitals.
As previously mentioned, a change in the ICU admission policy should be shared maximally among the staff involved. Moreover, the patients who are affected by the application of new, more stringent criteria of eligibility for ICU admission (and/or their proxies) should be informed of the extraordinary nature of the measures in place, as a matter of duty of transparency and to maintain confidence in the health service.
An additional aim of the recommendations is to support the clinicians when dealing with individual patients, as hard and complex decisions may be ethically and emotionally demanding.
Availability of data and materials
Marrazzo F, Migliari M, Stucchi R, Sforza A, Fumagalli R. The response of Milan’s Emergency Medical System to the COVID-19 outbreak in Italy. Lancet. 2020. https://doi.org/10.1016/S0140-6736(20)30493-1.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2002032.
Italian Ministry for Health. Statistical report on the National Health Service, 2017. Available at: http://www.salute.gov.it/portale/temi/p2_6.jsp?lingua=italiano&id=4603&area=statisticheSSN&menu=vuoto. Accessed 8 Mar 2020; website in Italian language.
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020. https://doi.org/10.1016/S2213-2600(20)30079-5.
Vergano M, Bertolini G, Giannini A, Gristina G, Livigni S, Mistraletti G, Riccioni L, Petrini F. SIAARTI Clinical Ethics Recommendations for the Allocation of Intensive Care Treatments in exceptional, resource-limited circumstances. Available at: https://bit.ly/2UyQ6I3. Accessed 24 Mar 2020; English version.
The authors did not receive any funding for this project.
Ethics approval and consent to participate
Consent for publication
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Vergano, M., Bertolini, G., Giannini, A. et al. Clinical ethics recommendations for the allocation of intensive care treatments in exceptional, resource-limited circumstances: the Italian perspective during the COVID-19 epidemic. Crit Care 24, 165 (2020). https://doi.org/10.1186/s13054-020-02891-w